MARKET

OPK

OPK

Opko Health
NASDAQ
1.340
-0.010
-0.74%
After Hours: 1.330 -0.01 -0.75% 19:56 12/05 EST
OPEN
1.330
PREV CLOSE
1.350
HIGH
1.360
LOW
1.330
VOLUME
1.39M
TURNOVER
--
52 WEEK HIGH
2.035
52 WEEK LOW
1.110
MARKET CAP
1.03B
P/E (TTM)
-5.5671
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at OPK last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at OPK last week (1117-1121)?
Weekly Report · 11/24 10:34
Nasdaq, IonQ, Opko, Exact, Palo Alto: Trending by Analysts
TipRanks · 11/22 09:01
CEO Makes Major Move with Massive Opko Health Stock Purchase!
TipRanks · 11/22 02:10
Opko Health CEO and Chairman Phillip Frost Reports Acquisition of Common Shares
Reuters · 11/21 22:07
Friday 11/21 Insider Buying Report: GLOO, OPK
NASDAQ · 11/21 18:32
OPKO Health (OPK): Valuation in Focus After CEO Phillip Frost's Significant Insider Share Purchase
Simply Wall St · 11/21 10:33
Opko Health’s CEO Makes a Bold Move with Massive Stock Purchase!
TipRanks · 11/21 02:13
More
About OPK
OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company’s segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of the pharmaceutical operations it operates in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its global pharmaceutical research and development operations. The diagnostics segment primarily consists of clinical laboratory operations through BioReference and its point-of-care operations. Its pharmaceutical business features Somatrogon (hGH-CTP), a once-weekly human growth hormone injection, and it is marketed under the brand name NGENLA. The Company, through its pharmaceutical division, manufactures and sells Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency.

Webull offers OPKO Health Inc stock information, including NASDAQ: OPK real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OPK stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OPK stock methods without spending real money on the virtual paper trading platform.